Status: Not yet recruiting
Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
To evaluate the efficacy of Megestrol Acetate Oral Suspension in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy in Malignant Solid Tumor Patients
Participants needed: 132
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Aug 19, 2025Locations: 1
Eligibility criteria
Age ≥ 18 years, regardless of sex [+4]